U.S. Markets open in 3 hrs 8 mins

Drug price fixing allegation may be increasingly problematic for makers: Analyst

David Maris, research analyst at Wells Fargo, joins CNBC's "Power Lunch" team to discuss how big drug makers are trading amid allegations of price fixing.